← Back to DWTX

Dogwood Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 07/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 07/11/2025Jun 2024Filed 07/11/2025Mar 2024Filed 07/11/2025
−$12−$5−$16−$3.8−$11−$2.3−$1−$1.3
−$0.34−$0.15−$8.20−$1.99−$8.45−$2.05−$1.15−$1.68
34341.91.91.41.1

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.